TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,198
|
1,093
|
1,116 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
203
|
348
|
275 |
| EBITDA |
193
|
324
|
281 |
| Total assets |
1,784
|
1,707
|
1,845 |
| Current assets |
1,265
|
1,436
|
1,720 |
| Current liabilities |
207
|
61
|
92 |
| Equity capital |
1,456
|
1,543
|
1,521 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.6%
|
90.4%
|
82.4% |
| Turnover per employee |
1,198
|
1,093
|
1,116 |
| Profit as a percentage of turnover |
16.9%
|
31.8%
|
24.6% |
| Return on assets (ROA) |
11.4%
|
20.4%
|
15.0% |
| Current ratio |
611.1%
|
2354.1%
|
1869.6% |
| Return on equity (ROE) |
13.9%
|
22.6%
|
18.1% |
| Change turnover |
28
|
10
|
-354 |
| Change turnover % |
2%
|
1%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.